GAP43 and lung cancer: GAP43 accelerates the malignant development of thyroid cancer cells through epithelial-mesenchymal transition (Zheng et al., 2019) and GAP43 was also reported to be associated with metastasis promotion in lung cancer (Zhang et al., 2018).